OBJECTIVE: We sought to directly compare the effects of type 1 and type 2 diabetes on postischemic neovascularization and evaluate the mechanisms underlying differences between these groups. We tested the hypothesis that type 2 diabetic mice have a greater reduction in endothelial nitric oxide synthase (eNOS) expression, a greater increase in oxidative stress, and reduced arteriogenesis and angiogenesis, resulting in less complete blood flow recovery than type 1 diabetic mice after induction of hind limb ischemia. METHODS: Hind limb ischemia was generated by femoral artery excision in streptozotocin-treated mice (model of type 1 diabetes), in Lepr(db/db) mice (model of type 2 diabetes), and in control (C57BL/6) mice. Dependent variables included eNOS expression and markers of arteriogenesis, angiogenesis, and oxidative stress. RESULTS: Postischemia recovery of hind limb perfusion was significantly less in type 2 than in type 1 diabetic mice; however, neither group demonstrated a significant increase in collateral artery diameter or collateral artery angioscore in the ischemic hind limb. The capillary/myofiber ratio in the gastrocnemius muscle decreased in response to ischemia in control or type 1 diabetic mice but remained the same in type 2 diabetic mice. Gastrocnemius muscle eNOS expression was lower in type 1 and 2 diabetic mice than in control mice. This expression decreased after induction of ischemia in type 2 but not in type 1 diabetic mice. The percentage of endothelial progenitor cells (EPC) in the peripheral blood failed to increase in either diabetic group after induction of ischemia, whereas this variable significantly increased in the control group in response to ischemia. EPC eNOS expression decreased after induction of ischemia in type 1 but not in type 2 diabetic mice. EPC nitrotyrosine accumulation increased after induction of ischemia in type 2 but not in type 1 diabetic mice. EPC migration in response to vascular endothelial growth factor was reduced in type 1 and type 2 diabetic mice vs control mice. EPC incorporation into tubular structures was less effective in type 2 diabetic mice. Extensive fatty infiltration was present in ischemic muscle of type 2 but not in type 1 diabetic mice. CONCLUSION: Type 2 diabetic mice displayed a significantly less effective response to hind limb ischemia than type 1 diabetic mice.
OBJECTIVE: We sought to directly compare the effects of type 1 and type 2 diabetes on postischemic neovascularization and evaluate the mechanisms underlying differences between these groups. We tested the hypothesis that type 2 diabeticmice have a greater reduction in endothelial nitric oxide synthase (eNOS) expression, a greater increase in oxidative stress, and reduced arteriogenesis and angiogenesis, resulting in less complete blood flow recovery than type 1 diabeticmice after induction of hind limb ischemia. METHODS: Hind limb ischemia was generated by femoral artery excision in streptozotocin-treated mice (model of type 1 diabetes), in Lepr(db/db) mice (model of type 2 diabetes), and in control (C57BL/6) mice. Dependent variables included eNOS expression and markers of arteriogenesis, angiogenesis, and oxidative stress. RESULTS:Postischemia recovery of hind limb perfusion was significantly less in type 2 than in type 1 diabeticmice; however, neither group demonstrated a significant increase in collateral artery diameter or collateral artery angioscore in the ischemic hind limb. The capillary/myofiber ratio in the gastrocnemius muscle decreased in response to ischemia in control or type 1 diabeticmice but remained the same in type 2 diabeticmice. Gastrocnemius muscle eNOS expression was lower in type 1 and 2 diabeticmice than in control mice. This expression decreased after induction of ischemia in type 2 but not in type 1 diabeticmice. The percentage of endothelial progenitor cells (EPC) in the peripheral blood failed to increase in either diabetic group after induction of ischemia, whereas this variable significantly increased in the control group in response to ischemia. EPC eNOS expression decreased after induction of ischemia in type 1 but not in type 2 diabeticmice. EPC nitrotyrosine accumulation increased after induction of ischemia in type 2 but not in type 1 diabeticmice. EPC migration in response to vascular endothelial growth factor was reduced in type 1 and type 2 diabeticmice vs control mice. EPC incorporation into tubular structures was less effective in type 2 diabeticmice. Extensive fatty infiltration was present in ischemic muscle of type 2 but not in type 1 diabeticmice. CONCLUSION:Type 2 diabeticmice displayed a significantly less effective response to hind limb ischemia than type 1 diabeticmice.
Authors: Vincent van Weel; Margreet de Vries; Peter J Voshol; Robert E Verloop; Paul H C Eilers; Victor W M van Hinsbergh; J Hajo van Bockel; Paul H A Quax Journal: Arterioscler Thromb Vasc Biol Date: 2006-03-30 Impact factor: 8.311
Authors: Thomas Thum; Daniela Fraccarollo; Maximilian Schultheiss; Sabrina Froese; Paolo Galuppo; Julian D Widder; Dimitrios Tsikas; Georg Ertl; Johann Bauersachs Journal: Diabetes Date: 2007-03 Impact factor: 9.461
Authors: Costanza Emanueli; Andrea Caporali; Nicolle Krankel; Brunella Cristofaro; Sophie Van Linthout; Paolo Madeddu Journal: Front Biosci Date: 2007-01-01
Authors: Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez Journal: J Clin Invest Date: 2007-05 Impact factor: 14.808
Authors: Sajoscha A Sorrentino; Ferdinand H Bahlmann; Christian Besler; Maja Müller; Svenja Schulz; Nina Kirchhoff; Carola Doerries; Tibor Horváth; Anne Limbourg; Florian Limbourg; Danilo Fliser; Hermann Haller; Helmut Drexler; Ulf Landmesser Journal: Circulation Date: 2007-06-25 Impact factor: 29.690
Authors: Christopher B Pattillo; Shyamal C Bir; Billy G Branch; Eric Greber; Xinggui Shen; Sibile Pardue; Rakesh P Patel; Christopher G Kevil Journal: Free Radic Biol Med Date: 2010-11-09 Impact factor: 7.376
Authors: T Driesen; D Schuler; R Schmetter; C Heiss; M Kelm; J W Fischer; T Freudenberger Journal: Histochem Cell Biol Date: 2015-11-02 Impact factor: 4.304
Authors: Chad L Carr; Yue Qi; Brian Davidson; Scott Chadderdon; Ananda R Jayaweera; J Todd Belcik; Cameron Benner; Aris Xie; Jonathan R Lindner Journal: Arterioscler Thromb Vasc Biol Date: 2011-11 Impact factor: 8.311
Authors: Richard A Cohen; Colin E Murdoch; Yosuke Watanabe; Victoria M Bolotina; Alicia M Evangelista; Dagmar J Haeussler; Melissa D Smith; Yu Mei; XiaoYong Tong; Jingyan Han; Jessica B Behring; Markus M Bachschmid; Reiko Matsui Journal: J Cardiovasc Pharmacol Date: 2016-06 Impact factor: 3.105
Authors: Ashay D Bhatwadekar; E P Guerin; Yagna P R Jarajapu; Sergio Caballero; Carl Sheridan; David Kent; Laurence Kennedy; M Cecilia Lansang; Frank W Ruscetti; Carl J Pepine; Paul J Higgins; Stephen H Bartelmez; Maria B Grant Journal: Diabetes Date: 2010-05-11 Impact factor: 9.461